White matter dementia

Therapeutic Advances in Neurological Disorders

Volumn 5, Issue 5, 2012, Pages 267-277

  Filley, Christopher M ^a  

^a Behavioral Neurology Section   (United States)

Author keywords

dementia; diffusion tensor imaging; disconnection; magnetic resonance spectroscopy; multiple sclerosis; myelin; toluene leukoencephalopathy; White matter

Indexed keywords

AGGRESSION; AGING; ALCOHOLISM; ALZHEIMER DISEASE; ATTENTION DEFICIT DISORDER; AUTISM; BEHAVIOR; BIPOLAR DISORDER; BRAIN CORTEX; BRAIN DEPTH STIMULATION; BRAIN FUNCTION; CEREBROVASCULAR DISEASE; COGNITION; COGNITIVE DEFECT; CREUTZFELDT JAKOB DISEASE; DECLARATIVE MEMORY; DEMENTIA; DIFFUSION TENSOR IMAGING; DISEASE SEVERITY; FRAGILE X SYNDROME; GLIOMA; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; HUNTINGTON CHOREA; HYPOXIA; IRON OVERLOAD; LEUKOARAIOSIS; LEUKOENCEPHALOPATHY; METACHROMATIC LEUKODYSTROPHY; MULTIINFARCT DEMENTIA; MULTIPLE SCLEROSIS; MYELINATION; MYOTONIC DYSTROPHY; NERVE DEGENERATION; NEUROFIBROMATOSIS; NEUROIMAGING; NEUROPATHOLOGY; NEUROSCIENCE; NORMOTENSIVE HYDROCEPHALUS; OBSESSIVE COMPULSIVE DISORDER; PARKINSON DISEASE; PHENYLKETONURIA; PRIORITY JOURNAL; REVIEW; SCLEROSIS; SYSTEMIC LUPUS ERYTHEMATOSUS; TRAUMATIC BRAIN INJURY; TUBEROUS SCLEROSIS; WHITE MATTER; WHITE MATTER DEMENTIA;

EID: 84870412068     PISSN: 17562856     EISSN: 17562864     Source Type: Journal    
DOI: 10.1177/1756285612454323     Document Type: Review

References (67)

1. Absinta M. Rocca M.A. Moiola L. Copetti M. Milani N. Falini A. et al. (2011) Cortical lesions in children with multiple sclerosis. Neurology 76: 910–913.
2. Albert M.L. Feldman R.G. Willis A.L. (1974) The ‘subcortical dementia’ of progressive supranuclear palsy. J Neurol Neurosurg Psychiatry 37: 121–130.
3. Al-Hajri Z. Del Bigio M.R. (2010) Brain damage in a large cohort of solvent abusers. Acta Neuropathol 119: 435–445.
4. Alix J.J. Domingues A.M. (2011) White matter synapses: form, function, and dysfunction. Neurology 76: 397– 404.
5. Amato M.P. Portaccio E. Goretti B. Zipoli V. Iudice A. Della Pina D. et al. (2010) Relevance of cognitive deterioration in early relapsing-remitting MS: a 3-year follow-up study. Mult Scler 16: 1474–1482.
6. American Psychiatric Association (1994). Diagnostic and Statistical Manual. 4th ed. American Psychiatric Association Press: Washington, D.C.
7. Bartzokis G. (2011) Alzheimer's disease as homeostatic responses to age-related myelin breakdown. Neurobiol Aging 32: 1341–1371
8. Bear D.M. (1997) Interictal behavior in temporal lobe epilepsy. In Ed. Schacter S. Devinsky O. (eds.) Behavioral neurology and the legacy of Norman Geschwind. Lippincott-Raven: Philadelphia.
9. Bengtsson S.L. Nagy Z. Skare S. Forsman L. Forssberg H. Ullén F. (2005) Extensive piano practicing has regionally specific effects on white matter development. Nat Neurosci 8: 1148–1150
10. Bonelli R.M. Cummings J.L. (2008) Frontal-subcortical dementias. Neurologist 14: 100–107.
11. Cosentino S. Jefferson A. Chute D.L. Kaplan E. Libon D.J. (2004) Clock drawing errors in dementia: neuropsychological and neuroanatomical considerations. Cogn Behav Neurol 17: 74–84.
12. Debette S. Markus H.S. (2010) The clinical importance of white matter hyperintensities on brain magnetic resonance imaging: systematic review and meta-analysis. BMJ 26; 341: c3666
13. Dubois B. Slachevsky A. Litvan I. Pillon B. (2000) The FAB: a Frontal Assessment Battery at bedside. Neurology 55: 1621–1626.
14. Fields R.D. (2010) Neuroscience. Change in the brain's white matter. Science 330: 768–769.
15. Filley C.M. (2010) White matter: organization and functional relevance. Neuropsychol Rev 20: 158–173.
16. Filley C.M. (2011 a) White matter: beyond focal disconnection. Neurol Clin 29: 81–97.
17. Filley C.M. (2011 b) Neurobehavioral anatomy, 3nd ed. University Press of Colorado: Boulder, CO.
18. Filley C.M. (2012) The behavioral neurology of white matter. 2nd ed. Oxford University Press: New York.
19. Filley C.M. Franklin G.M. Heaton R.K. Rosenberg N.L. (1988) White matter dementia: clinical disorders and implications. Neuropsychiatry Neuropsychol Behav Neurol 1: 239–254.
20. Filley C.M. Heaton R.K. Rosenberg N.L. (1990) White matter dementia in chronic toluene abuse. Neurology 40: 532–534.
21. Filley C.M. Heaton R.K. Nelson L.M. Burks J.S. Franklin G.M. (1989) A comparison of dementia in Alzheimer's Disease and multiple sclerosis. Arch Neurol 46: 157–161.
22. Filley C.M. (1998) The behavioral neurology of cerebral white matter. Neurology 50: 1535–1540.
23. Filley C.M. Kleinschmidt-De Masters B.K. (2001) Toxic leukoencephalopathy. N Engl J Med 345: 425–432.
24. Filley C.M. Halliday W. Kleinschmidt-De Masters B.K. (2004) The effects of toluene on the central nervous system. J Neuropathol Exp Neurol 63: 1–12.
25. Filley C.M. Kozora E. Brown M.S. Miller D.E. West S.G. Arciniegas D.B. et al. (2009) White matter microstructure and cognition in non-neuropsychiatric systemic lupus erythematosus. Cogn Behav Neurol 22: 38–44.
26. Fischer J.S. Priore R.L. Jacobs L.D. Cookfair D.L. Rudick R.A. Herndon R, M. et al (2000) Neuropsychological effects of interferon beta-1a in relapsing multiple sclerosis. Multiple Sclerosis Collaborative Research Group. Ann Neurol 48: 885–892.
27. Folstein M.F. Folstein S.E. McHugh P.R. (1975) “Mini-mental state”. A practical method for grading the cognitive state of patients for the clinician. J Psychiatr Res 12: 189–198.
28. Franklin G.M. Heaton R.K. Nelson L.M. Filley C.M. Seibert C. (1988) Correlation of neuropsychological and MRI findings in chronic / progressive multiple sclerosis. Neurology 38: 1826–1829.
29. Franklin G.M. Nelson L.M. Filley C.M. Heaton R.K. (1989) Cognitive loss in multiple sclerosis. Case reports and review of the literature. Arch Neurol 46: 162–167.
30. Geschwind N. (1965) Disconnexion syndromes in animals and man. Brain 88: 237-294, 585–644.
31. Gold B.T. Powell D.K. Andersen A.H. Smith C.D. (2010) Alterations in multiple measures of white matter integrity in normal women at high risk for Alzheimer's disease. Neuroimage 52: 1487–1494.
32. Goldman S.A. (2007).Disease targets and strategies for the therapeutic modulation of endogenous neural stem and progenitor cells. Clin Pharmacol Ther 82: 453–460.
33. Greenberg B.D. Malone D.A. Friehs G.M. Rezai A.R. Kubu C.S. Malloy P.F. et al. (2006) Three-year outcomes in deep brain stimulation for highly resistant obsessive-compulsive disorder. Neuropsychopharmacology 31: 2384–2393.
34. Griebe M. Förster A. Wessa M. Rossmanith C. Bäzner H. Sauer T. et al. (2011) Loss of callosal fibre integrity in healthy elderly with age-related white matter changes. J Neurol 258: 1451–1459.
35. Hardy J. (2009) The amyloid hypothesis for Alzheimer's disease: a critical reappraisal. J Neurochem 10: 1129–1134.
36. Hormes J.T. Filley C.M. Rosenberg N.L. (1986) Neurologic sequelae of chronic solvent vapor abuse. Neurology 36: 698–702.
37. Inzitari D. Pracucci G. Poggesi A. Carlucci G. Barkhof F. Chabriat H. et al. (2009) Changes in white matter as determinant of global functional decline in older independent outpatients: three year follow-up of LADIS (leukoaraiosis and disability) study cohort. BMJ 6; 339: b2477
38. Kanno S. Abe N. Saito M. Takagi M. Nishio Y. Hayashi A. et al. (2011) White matter involvement in idiopathic normal pressure hydrocephalus: a voxel-based diffusion tensor imaging study. J Neurol 258: 1949–1957.
39. Kim Y.S. Lee K.M. Choi B.H. Sohn E.H. Lee A.Y. (2009) Relation between the clock drawing test (CDT) and structural changes of brain in dementia. Arch Gerontol Geriatr 48: 218–221.
40. Kozora E. Filley C.M. (2011) Cognitive dysfunction and white matter abnormalities in systemic lupus erythematosus. J Int Neuropsychol Soc; 17: 1–8.
41. Krivit W. Peters C. Shapiro E.G. (1999) Bone marrow transplantation as effective treatment of central nervous system disease in globoid cell leukodystrophy, metachromatic leukodystrophy, adrenoleukodystrophy, mannosidosis, fucosidosis, aspartylglucosaminuria, Hurler, Maroteaux-Lamy, and Sly syndromes, and Gaucher disease type III. Curr Opin Neurol 12: 167–176.
42. Lafosse J.M. Corboy J.R. Leehey M.A. Seeberger L.C. Filley C.M. (2007) MS vs. HD: Can white matter and subcortical gray matter pathology be distinguished neuropsychologically? J Clin Exp Neuropsychol 29: 142–154.
43. Leone P. Janson C.G. Bilianuk L. Wang Z. Sorgi F. Huang L. et al (2000) Aspartoacylase gene transfer to the mammalian central nervous system with therapeutic implications for Canavan's disease. Ann Neurol 48: 27–38.
44. Lucchinetti C.F. Popescu B.F. Bunyan R.F. Moll N.M. Roemer S.F. Lassmann H. et al. (2011). Inflammatory cortical demyelination in early multiple sclerosis. N Engl J Med 365: 2188–2197.
45. Mayberg H.S. Lozano A.M. Voon V. McNeely H.E. Seminowicz D. Hamani C. et al. (2005) Deep brain stimulation for treatment-resistant depression. Neuron 45: 651–660.
46. McHugh P.R. Folstein M.F. (1975) Psychiatric syndromes of Huntington's Chorea. In: Ed. Benson D.F. Blumer D. (eds.) Psychiatric aspects of neurologic disease, vol. 1. Grune and Stratton: New York.
47. McKhann G. Drachman D. Folstein M. Katzman R. Price D. Stadlan E.M. (1984) Clinical diagnosis of Alzheimer's disease: report of the NINCDS-ADRDA Work Group under the auspices of Department of Health and Human Services Task Force on Alzheimer's Disease. Neurology 34: 939–944.
48. Medana I.M. Esiri M.M. (2003) Axonal damage: a key predictor of outcome in human CNS diseases. Brain 26: 515–530.
49. Mesulam M. (2011) The evolving landscape of human cortical connectivity: Facts and inferences. Neuroimage Dec 22 [Epub ahead of print]
50. Nasreddine Z.S. Phillips N.A. Bédirian V. Charbonneau S. Whitehead V. Collin I. et al. (2005) The Montreal Cognitive Assessment, MoCA: a brief screening tool for mild cognitive impairment. J Am Geriatr Soc 53: 695–699.
51. Parvizi J. (2009) Corticocentric myopia: old bias in new cognitive sciences. Trends Cogn Sci 13: 354–359.
52. Penke L. Muñoz Maniega S. Murray C. Gow A.J. Hernández M.C. Clayden J.D. et al. (2010) A general factor of brain white matter integrity predicts information processing speed in healthy older people. J Neurosci 30: 7569–7574.
53. Petersen R.C. (2011) Clinical practice. Mild cognitive impairment. N Engl J Med 364: 2227–2234.
54. Querfurth H.W. LaFerla F.M. (2010) Alzheimer's disease. N Engl J Med 362: 329–344.
55. Rosenberg N.L. Kleinschmidt-De Masters B.K. Davis K.A. Dreisbach J.N. Hormes J.T. Filley C.M. (1988) Toluene abuse causes diffuse central nervous system white matter changes. Ann Neurol 23: 611–614.
56. Schlaug G. Marchina S. Norton A. (2009) Evidence for plasticity in white-matter tracts of patients with chronic Broca's aphasia undergoing intense intonation-based speech therapy. Ann N Y Acad Sci 1169: 385–394.
57. Schmahmann J.D. Pandya D.N. (2006). Fiber pathways of the brain. Oxford University Press: New York.
58. Schmahmann J.D. Pandya D.N. (2008) Disconnection syndromes of basal ganglia, thalamus, and cerebrocerebellar systems. Cortex 44: 1037–1066
59. Schmahmann J.D. Smith E.E. Eichler F.S. Filley C.M. (2008) Cerebral white matter: neuroanatomy, clinical neurology, and neurobehavioral correlates. Ann NY Acad Sci 1142: 266–309.
60. Sporns O. (2011) The human connectome: a complex network. Ann N Y Acad Sci 1224:
61. Swirsky-Sacchetti T. Field H.L. Mitchell D.R. Seward J. Lublin F.D. Knobler R.L. et al. (1992) The sensitivity of the Mini-Mental State Exam in the white matter dementia of multiple sclerosis. J Clin Psychol 48: 779–786.
62. Tran K.D. Ho A. Jandial R. (2010) Stem cell transplantation methods. Adv Exp Med Biol 671: 41–57.
63. Trapp B.D. Peterson J. Ransohoff R.M. Rudick R. Mörk S. Bö L. (1998) Axonal transection in the lesions of multiple sclerosis. N Engl J Med 338: 278–285.
64. Tumani H. Uttner I. (2007) Influences on cognition by immunosuppression and immunomodulation in multiple sclerosis. J Neurol 254 Suppl 2: II69–II72
65. Turken A. Whitfield-Gabrieli S. Bammer R. Baldo J.V. Dronkers N.F. Gabrieli J.D. (2008) Cognitive processing speed and the structure of white matter pathways: convergent evidence from normal variation and lesion studies. Neuroimage 42: 1032–1044.
66. Wake H. Lee P.R. Fields R.D. (2011) Control of local protein synthesis and initial events in myelination by action potentials. Science 333: 1647–1651.
67. Yücel M. Takagi M. Walterfang M. Lubman D.I. (2008). Toluene misuse and long-term harms: a systematic review of the neuropsychological and neuroimaging literature. Neurosci Biobehav Rev 32: 910–926.